BRCA1 and p53 tumor suppressor molecules in Alzheimer’S disease

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 2879-2892

  Nakanishi, Atsuko ^a   Minami, Akari ^a   Kitagishi, Yasuko ^a   Ogura, Yasunori ^a   Matsuda, Satoru ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Alzheimer s disease; BRCA1; Cell signaling; Dietary supplementation; DNA repair; p53; Tumor suppressor

Indexed keywords

3 INDOLEMETHANOL; ACETYLCHOLINESTERASE; ANTIOXIDANT; ATM PROTEIN; BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; GENISTEIN; GINSENOSIDE; MAGNOLIA OFFICINALIS EXTRACT; MESSENGER RNA; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; PHYTOESTROGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53; RAD50 PROTEIN; RAD51 PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COGNITIVE DEFECT; DIET SUPPLEMENTATION; DISEASE COURSE; DNA REPAIR; GLEDITSIA; HOMEOSTASIS; HUMAN; MAGNOLIA OFFICINALIS; NEOPLASM; NERVE CELL NECROSIS; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; SAUSSUREA; SIGNAL TRANSDUCTION; DNA DAMAGE; METABOLISM; NERVE CELL; PATHOLOGY;

ALZHEIMER DISEASE; BRCA1 PROTEIN; DNA DAMAGE; DNA REPAIR; HUMANS; NEURONS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84922021713     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16022879     Document Type: Article

References (87)

1. Shastry, B.S. Molecular genetics of familial Alzheimer disease. Am. J. Med. Sci. 1998, 315, 266-272.
2. Mazza, M.; Marano, G.; Traversi, G.; Bria, P.; Mazza, S. Primary cerebral blood flow deficiency and Alzheimer's disease: Shadows and lights. J. Alzheimers Dis. 2011, 23, 375-389.
3. Bloom, G.S. Amyloid-β and Tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014, 71, 505-508.
4. Reddy, P.H. Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage. Biochim. Biophys. Acta 2013, 1832, 1913-1921.
5. Herholz, K.; Ebmeier, K. Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol. 2011, 10, 667-670.
6. Driver, J.A.; Lu, K.P. Pin1: A new genetic link between Alzheimer's disease, cancer and aging. Curr. Aging Sci. 2010, 3, 158-165.
7. Madabhushi, R.; Pan, L.; Tsai, L.H. DNA damage and its links to neurodegeneration. Neuron 2014, 83, 266-282.
8. Lambeth, J.D. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 2007, 43, 332-347.
9. Heijink, A.M.; Krajewska, M.; van Vugt, M.A. The DNA damage response during mitosis. Mutat. Res. 2013, 750, 45-55.
10. Kaufmann, W.K. Initiating the uninitiated: Replication of damaged DNA and carcinogenesis. Cell Cycle 2007, 6, 1460-1467.
11. Neganova, I.; Vilella, F.; Atkinson, S.P.; Lloret, M.; Passos, J.F.; von Zglinicki, T.; O'Connor, J.E.; Burks, D.; Jones, R.; Armstrong, L.; et al. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011, 29, 651-659.
12. Lavin, M.F.; Concannon, P.; Gatti, R.A. Eighth International Workshop on Ataxia-Telangiectasia (ATW8). Cancer Res. 1999, 59, 3845-3849.
13. Zinn, P.O.; Sathyan, P.; Mahajan, B.; Bruyere, J.; Hegi, M.; Majumder, S.; Colen, R.R. A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature. PLoS One 2012, 7, e41522.
14. Menendez, J.A.; Mehmi, I.; Atlas, E.; Colomer, R.; Lupu, R. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-κB. Int. J. Oncol. 2004, 24, 591-608.
15. Pavard, S.; Metcalf, C.J. Negative selection on BRCA1 susceptibility alleles sheds light on the population genetics of late-onset diseases and aging theory. PLoS One 2007, 2, e1206.
16. Katsel, P.; Tan, W.; Fam, P.; Purohit, D.P.; Haroutunian, V. Correction: Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease. PLoS One 2013, 8, e68361.
17. Jeppesen, D.K.; Bohr, V.A.; Stevnsner, T. DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 2011, 94, 166-200.
18. Kirkland, J.B. Niacin requirements for genomic stability. Mutat. Res. 2012, 733, 14-20.
19. House, N.C.; Koch, M.R.; Freudenreich, C.H. Chromatin modifications and DNA repair: Beyond double-strand breaks. Front. Genet. 2014, 5, 296, doi:10.3389/fgene.2014.00296.
20. Roos, W.P.; Kaina, B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett. 2013, 332, 237-248.
21. Hemström, T.H.; Joseph, B.; Schulte, G.; Lewensohn, R.; Zhivotovsky, B. PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage. Exp. Cell Res. 2005, 305, 200-213.
22. Zhao, T.; Jia, H.; Li, L.; Zhang, G.; Zhao, M.; Cheng, Q.; Zheng, J.; Li, D. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines. Oncol. Rep. 2013, 30, 377-384.
23. Cantor, S.B.; Guillemette, S. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol. 2011, 7. 253-261.
24. Konishi, H.; Mohseni, M.; Tamaki, A.; Garay, J.P.; Croessmann, S.; Karnan, S.; Ota, A.; Wong, H.Y.; Konishi, Y.; Karakas B; et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc. Natl. Acad. Sci. USA 2011, 108, 17773-17778.
25. Salmena, L.; Narod, S. BRCA1 haploinsufficiency: Consequences for breast cancer. Womens Health 2012, 8, 127-129.
26. Chai, Y.; Salmena, G.; Cui, J.; Liao, B.; Liu, S.; Aysola, K.; Yezdani, M.; Reddy, E.S.; Rao, V.N. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene 2001, 20, 1357-1367.
27. Le Page, F.; Randrianarison, V.; Marot, D.; Cabannes, J.; Perricaudet, M.; Feunteun, J.; Sarasin, A. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res. 2000, 60, 5548-5552.
28. Helmer, R.A.; Martínez-Zaguilán, R.; Dertien, J.S.; Fulford, C.; Foreman, O.; Peiris, V.; Chilton, B.S. Helicase-like transcription factor (Hltf) regulates G2/M transition, Wt1/Gata4/Hif-1a cardiac transcription networks, and collagen biogenesis. PLoS One 2013, 8, e80461.
29. Singh, K.K.; Shukla, P.C.; Quan, A.; Al-Omran, M.; Lovren, F.; Pan, Y.; Brezden-Masley, C.; Ingram, A.J.; Stanford, W.L.; Teoh, H.; et al. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis. J. Thorac. Cardiovasc. Surg. 2013, 146, 949-960.e4.
30. Bradley-Whitman, M.A.; Timmons, M.D.; Beckett, T.L.; Murphy, M.P.; Lynn, B.C.; Lovell, M.A. Nucleic acid oxidation: An early feature of Alzheimer's disease. J. Neurochem. 2014, 128, 294-304.
31. Falik-Zaccai, T.C.; Keren, Z.; Slor, H. The versatile DNA nucleotide excision repair (NER) and its medical significance. Pediatr. Endocrinol. Rev. 2009, 7, 37-42.
32. Keimpema, E.; Tortoriello, G.; Alpár, A.; Capsoni, S.; Arisi, I.; Calvigioni, D.; Hu, S.S.; Cattaneo, A.; Doherty, P.; Mackie, K.; et al. Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. Proc. Natl. Acad. Sci. USA 2013, 110, 1935-1940.
33. Monteiro, A.N.; August, A.; Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 1996, 93, 13595-13599.
34. Ayi, T.C.; Tsan, J.T.; Hwang, L.Y.; Bowcock, A.M.; Baer, R. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein. Oncogene 1998, 17, 2143-2148.
35. Reedy, M.B.; Hang, T.; Gallion, H.; Arnold, S.; Smith, S.A. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis. Gynecol. Oncol. 2001, 81, 441-446.
36. Jhanwar-Uniyal, M. BRCA1 in cancer, cell cycle and genomic stability. Front. Biosci. 2003, 8, s1107-s1117.
37. Cousineau, I.; Abaji, C.; Belmaaza, A. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: Implications for sister chromatid cohesion, genome stability, and carcinogenesis. Cancer Res. 2005, 65, 11384-11391.
38. Song, M.; Kwon, Y.A.; Lee, Y.; Kim, H.; Yun, J.H.; Kim, S.; Kim, D.K. G1/S cell cycle checkpoint defect in lymphocytes from patients with Alzheimer's disease. Psychiatry Investig. 2012, 9, 413-417.
39. Jacobsen, E.; Beach, T.; Shen, Y.; Li, R.; Chang, Y. Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains. Brain Res. Mol. Brain Res. 2004, 128, 1-7.
40. Kim, S.S.; Cao, L.; Li, C.; Xu, X.; Huber, L.J.; Chodosh, L.A.; Deng, C.X. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1. Mol. Cell Biol. 2004, 24, 9498-9507.
41. Coene, E.D.; Hollinshead, M.S.; Waeytens, A.A.; Schelfhout, V.R.; Eechaute, W.P.; Shaw, M.K.; van Oostveldt, P.M.; Vaux, D.J. Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol. Biol. Cell 2005, 16, 997-1010.
42. Rolyan, H.; Scheffold, A.; Heinrich, A.; Begus-Nahrmann, Y.; Langkopf, B.H.; Hölter, S.M.; Vogt-Weisenhorn, D.M.; Liss, B.; Wurst, W.; Lie, D.C.; et al. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice. Brain 2011, 134, 2044-2056.
43. Lanni, C.; Racchi, M.; Memo, M.; Govoni, S.; Uberti, D. p53 at the crossroads between cancer and neurodegeneration. Free Radic. Biol. Med. 2012, 52, 1727-1733.
44. Behrens, M.I.; Lendon, C.; Roe, C.M. A common biological mechanism in cancer and Alzheimer's disease? Curr. Alzheimer Res. 2009, 6, 196-204.
45. Ding, S.L.; Sheu, L.F.; Yu, J.C.; Yang, T.L.; Chen, B.F.; Leu, F.J.; Shen, C.Y. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade. Br. J. Cancer 2004, 90, 1995-2001.
46. Gartel, A.L. P21(WAF1/CIP1) may be a tumor suppressor after all. Cancer Biol. Ther. 2007, 6, 1171-1172.
47. Esteras, N.; Alquézar, C.; Bermejo-Pareja, F.; Bialopiotrowicz, E.; Wojda, U.; Martín-Requero, A. Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer's disease patients. Neurobiol. Aging 2013, 34, 1090-1100.
48. Bialopiotrowicz, E.; Szybinska, A.; Kuzniewska, B.; Buizza, L.; Uberti, D.; Kuznicki, J.; Wojda, U. Highly pathogenic Alzheimer's disease presenilin 1 P117R mutation causes a specific increase in p53 and p21 protein levels and cell cycle dysregulation in human lymphocytes. J. Alzheimers Dis. 2012, 32, 397-415.
49. Muñoz-Fontela, C.; Macip, S.; Martínez-Sobrido, L.; Brown, L.; Ashour, J.; García-Sastre, A.; Lee, S.W.; Aaronson, S.A. Transcriptional role of p53 in interferon-mediated antiviral immunity. J. Exp. Med. 2008, 205, 1929-1938.
50. Gehrau, R.C.; D'Astolfo, D.S.; Andreoli, V.; Bocco, J.L.; Koritschoner, N.P. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells. Mutat. Res. 2011, 707, 15-23.
51. Ward, A.; Hudson, J.W. p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress. PLoS One 2014, 9, e87918.
52. Chavez-Perez, V.A.; Strasberg-Rieber, M.; Rieber, M. Hypoxia and hypoxia mimetic cooperate to counteract tumor cell resistance to glucose starvation preferentially in tumor cells with mutant p53. Biochem. Biophys. Res. Commun. 2014, 443, 120-125.
53. Wiech, M.; Olszewski, M.B.; Tracz-Gaszewska, Z.; Wawrzynow, B.; Zylicz, M.; Zylicz, A. Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2. PLoS One 2012, 7, e51426.
54. Petitjean, A.; Achatz, M.I.; Borresen-Dale, A.L.; Hainaut, P.; Olivier, M. TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene 2007, 26, 2157-2165.
55. Pant, V.; Lozano, G. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev. 2014, 28, 1739-1751.
56. Hollstein, M.; Hainaut, P. Massively regulated genes: The example of TP53. J. Pathol. 2010, 220, 164-173.
57. Chalabi, N.; le Corre, L.; Maurizis, J.C.; Bignon, Y.J.; Bernard-Gallon, D.J. The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur. J. Cancer 2004, 40, 1768-1775.
58. Chalabi, N.; Maurizis, J.C.; le Corre, L.; Delort, L.; Bignon, Y.J.; Bernard-Gallon, D.J. Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment. J. Chromatogr. B 2005, 821, 188-193.
59. Lebda, M.A.; El-Neweshy, M.S.; El-Sayed, Y.S. Neurohepatic toxicity of subacute manganese chloride exposure and potential chemoprotective effects of lycopene. Neurotoxicology 2012, 33, 98-104.
60. Bosviel, R.; Dumollard, E.; Déchelotte, P.; Bignon, Y.J.; Bernard-Gallon, D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS 2012, 16, 235-244.
61. Vissac-Sabatier, C.; Coxam, V.; Déchelotte, P.; Picherit, C.; Horcajada, M.N.; Davicco, M.J.; Lebecque, P.; Bignon, Y.J.; Bernard-Gallon, D. Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats. Cancer Res. 2003, 63, 6607-6612.
62. Cabanes, A.; Wang, M.; Olivo, S.; DeAssis, S.; Gustafsson, J.A.; Khan, G.; Hilakivi-Clarke, L. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 2004, 25, 741-748.
63. Fan, S.; Meng, Q.; Auborn, K.; Carter, T.; Rosen, E.M. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br. J. Cancer 2006, 94, 407-426.
64. Soni, M.; Rahardjo, T.B.; Soekardi, R.; Sulistyowati, Y.; Lestariningsih; Yesufu-Udechuku, A.; Irsan, A.; Hogervorst, E. Phytoestrogens and cognitive function: A review. Maturitas 2014, 77, 209-220.
65. Hsieh, T.C.; Wu, J.M. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res. 2009, 29, 4025-4032.
66. Adjakly, M.; Bosviel, R.; Rabiau, N.; Boiteux, J.P.; Bignon, Y.J.; Guy, L.; Bernard-Gallon, D. DNA methylation and soy phytoestrogens: Quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 2011, 3, 795-803.
67. Dagdemir, A.; Durif, J.; Ngollo, M.; Bignon, Y.J.; Bernard-Gallon, D. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Epigenomics 2013, 5, 51-63.
68. Roccisano, D.; Henneberg, M.; Saniotis, A. A possible cause of Alzheimer's dementia-Industrial soy foods. Med. Hypotheses 2014, 82, 250-254.
69. Guo, X.X.; Li, Y.; Sun, C.; Jiang, D.; Lin, Y.J.; Jin, F.X.; Lee, S.K.; Jin, Y.H. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell 2014, 5, 224-234.
70. Zhang, X.; Wang, J.; Xing, Y.; Gong, L.; Li, H.; Wu, Z.; Li, Y.; Wang, J.; Wang, Y.; Dong, L.; Li, S. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease. Neuroscience 2012, 220, 191-200.
71. Liu, J.; Yan, X.; Li, L.; Zhu, Y.; Qin, K.; Zhou, L.; Sun, D.; Zhang, X.; Ye, R.; Zhao, G. Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease. Neurochem. Res. 2012, 37, 2738-2747.
72. Gali-Muhtasib, H.; Diab-Assaf, M.; Boltze, C.; Al-Hmaira, J.; Hartig, R.; Roessner, A.; Schneider-Stock, R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int. J. Oncol. 2004, 25, 857-866.
73. Alhebshi, A.H.; Gotoh, M.; Suzuki, I. Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. Biochem. Biophys. Res. Commun. 2013, 433, 362-367.
74. Khan, A.; Vaibhav, K.; Javed, H.; Khan, M.M.; Tabassum, R.; Ahmed, M.E.; Srivastava, P.; Khuwaja, G.; Islam, F.; Siddiqui, M.S.; et al. Attenuation of Aβ-induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress. Mol. Cell. Biochem. 2012, 369, 55-65.
75. Lee, S.J.; Kim, H.M.; Cho, Y.H.; Park, K.; Kim, E.J.; Jung, K.H.; Kim, C.H.; Kim, W.J.; Moon, S.K. Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-α-induced NF-κB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase. Oncol. Rep. 2007, 18, 729-736.
76. Lee, Y.J.; Choi, D.Y.; Han, S.B.; Kim, Y.H.; Kim, K.H.; Hwang, B.Y.; Kang, J.K.; Lee, B.J.; Oh, K.W.; Hong, J.T. Inhibitory effect of ethanol extract of Magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer's disease via regulating β-secretase activity. Phytother. Res. 2012, 26, 1884-1892.
77. Hoi, C.P.; Ho, Y.P.; Baum, L.; Chow, A.H. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res. 2010, 24, 1538-1542.
78. Dong, L.H.; Wen, J.K.; Miao, S.B.; Jia, Z.; Hu, H.J.; Sun, R.H.; Wu, Y.; Han, M. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia. Cell Res. 2010, 20, 1252-1262.
79. Chen, C.; Li, X.; Gao, P.; Tu, Y.; Zhao, M.; Li, J.; Zhang, S.; Liang, H. Baicalin attenuates Alzheimer-like pathological changes and memory deficits induced by amyloid β1-42 protein. Metab. Brain Dis. 2014, doi:10.1007/s11011-014-9601-9.
80. Lee, S.J.; Park, K.; Ha, S.D.; Kim, W.J.; Moon, S.K. Gleditsia sinensis thorn extract inhibits human colon cancer cells: The role of ERK1/2, G2/M-phase cell cycle arrest and p53 expression. Phytother. Res. 2010, 24, 1870-1876.
81. Lee, S.J.; Ryu, D.H.; Jang, L.C.; Cho, S.C.; Kim, W.J.; Moon, S.K. Suppressive effects of an ethanol extract of Gleditsia sinensis thorns on human SNU-5 gastric cancer cells. Oncol. Rep. 2013, 29, 1609-1616.
82. Lu, Y.; Li, C.S.; Dong, Q. Chinese herb related molecules of cancer-cell-apoptosis: A minireview of progress between Kanglaite injection and related genes. J. Exp. Clin. Cancer Res. 2008, 27, 31, doi:10.1186/1756-9966-27-31.
83. Lin, Y.C.; Hung, C.M.; Tsai, J.C.; Lee, J.C.; Chen, Y.L.; Wei, C.W.; Kao, J.Y.; Way, T.D. Hispidulin potently inhibits human glioblastoma multiforme cells through activation of AMP-activated protein kinase (AMPK). J. Agric. Food Chem. 2010, 58, 9511-9517.
84. Bai, L.; Merchant, J.L. ZBP-89 promotes growth arrest through stabilization of p53. Mol. Cell Biol. 2001, 21, 4670-4683.
85. Hao, Q.; Maret, W. Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J. Alzheimers Dis. 2005, 8, 161-170.
86. Hancock, S.M.; Finkelstein, D.I.; Adlard, P.A. Glia and zinc in ageing and Alzheimer's disease: A mechanism for cognitive decline? Front. Aging Neurosci. 2014, 6, doi:10.3389/fnagi.2014.00137.
87. Olcina, M.; Lecane, P.S.; Hammond, E.M. Targeting hypoxic cells through the DNA damage response. Clin. Cancer Res. 2010, 16, 5624-5629.